• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

60.30 +0.57 (+0.95%)
Official Closing Price Updated: 7:00 PM EST, Feb 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 13,325,257
Open 59.85
Bid (Size) 60.30 (900)
Ask (Size) 60.40 (1,000)
Prev. Close 59.73
Today's Range 59.23 - 60.36
52wk Range 42.52 - 63.33
Shares Outstanding 2,222,113,553
Dividend Yield 4.18%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Incredibly Cheap Dividend Stocks to Buy Now ↗
Today 17:01 EST
Yes, there are bargains out there for investors seeking income-paying stocks. 
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Stocks to Buy and Hold for 2026 and Beyond ↗
Today 12:35 EST
Any of these three pharmaceutical titans could move the needle in your portfolio. 
Via The Motley Fool
Topics Economy Intellectual Property

Performance

YTD
+12.8%
+12.8%
1 Month
+11.2%
+11.2%
3 Month
+31.3%
+31.3%
6 Month
+24.5%
+24.5%
1 Year
+9.7%
+9.7%

More News

Read More
News headline image
Cytokinetics Secures Triple Crown: EU Approval of MYQORZO Solidifies Global Reach in Cardiovascular Market
Today 10:36 EST
Via MarketMinute
Bristol-Myers Squibb Co (NYSE:BMY) Offers a High Yield and Durable Dividend for Income Investors ↗
February 18, 2026
Via Chartmill
Bristol Myers Squibb Co (NYSE:BMY) Beats Q4 2025 Earnings Estimates and Provides Strong 2026 Outlook ↗
February 05, 2026
Via Chartmill
News headline image
ImmunityBio (IBRX): The Rise of Immunotherapy 2.0 and the Global Expansion of ANKTIVA
Today 10:03 EST
Via Finterra
Topics Lawsuit
News headline image
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
February 17, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
The 5 Most Interesting Analyst Questions From Bristol-Myers Squibb’s Q4 Earnings Call
February 12, 2026
Via StockStory
Topics Earnings
News headline image
Incyte (INCY) Deep Dive: Navigating the 2026 Crossroads Following Earnings Miss
February 11, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
The Great Pipeline Grab: Life Sciences Deal Volume Skyrockets 82% as Big Pharma Battles the Patent Cliff
February 06, 2026
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Roivant Sciences (ROIV): Anatomy of a 15% Surge and the Future of the ‘Vant’ Model
February 06, 2026
Via Finterra
Topics ETFs Economy Initial Public Offering
News headline image
BMY Q4 Deep Dive: Growth Portfolio Offsets Legacy Pressure, Pipeline Readouts in Focus
February 06, 2026
Via StockStory
News headline image
Why Bristol Myers Squibb Stock Topped the Market Today ↗
February 05, 2026
Via The Motley Fool
News headline image
Bristol Myers (BMY) Q4 2025 Earnings Transcript ↗
February 05, 2026
Via The Motley Fool
News headline image
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025
February 05, 2026
Via StockStory
News headline image
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
February 05, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi
February 04, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
Bristol Myers Q4 Earnings Preview: Profits Under Pressure Even As Wall Street Bets On 2026 Pipeline ↗
February 04, 2026
Via Stocktwits
Topics Artificial Intelligence Intellectual Property Workforce
News headline image
Bristol-Myers Squibb Earnings: What To Look For From BMY
February 03, 2026
Via StockStory
News headline image
Bristol Myers Squibb Introduces "Change the Target. Change What’s Possible.” to Highlight Unmet Needs in Cardiovascular and Thromboembolic Care
February 03, 2026
From Bristol Myers Squibb
Via Business Wire
News headline image
The Pharma Reckoning: 2026 Earnings Unveil a New Era of 'TrumpRx' Deals and Looming Patent Cliffs
February 02, 2026
Via MarketMinute
Topics Economy Government Intellectual Property
News headline image
The Sound of Silence: Revolution Medicines Plummets 17% as M&A Hopes Evaporate
February 02, 2026
Via MarketMinute
Topics ETFs Government Initial Public Offering
News headline image
3 Top Dividend Stocks Yielding More Than 4% to Buy Hand Over Fist This Year ↗
January 30, 2026
Via The Motley Fool
Topics Artificial Intelligence Intellectual Property World Trade

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 60.30
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 02/19/26 07:00 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 133.99B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 134B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap